Estimated 0 9 0 9 O
life 10 14 10 14 B-clinical_variable
expectancy 15 25 15 25 I-clinical_variable
of 26 28 26 28 O
at 29 31 29 31 O
least 32 37 32 37 O
12 38 40 38 40 B-lower_bound
weeks 41 46 41 46 I-lower_bound

History 0 7 47 54 O
of 8 10 55 57 O
allergic 11 19 58 66 O
reactions 20 29 67 76 O
attributed 30 40 77 87 O
to 41 43 88 90 O
compounds 44 53 91 100 O
of 54 56 101 103 O
similar 57 64 104 111 O
chemical 65 73 112 120 O
or 74 76 121 123 O
biologic 77 85 124 132 O
composition 86 97 133 144 O
to 98 100 145 147 O
cetuximab 101 110 148 157 B-allergy_name
or 111 113 158 160 O
other 114 119 161 166 O
agents 120 126 167 173 O
used 127 131 174 178 O
in 132 134 179 181 O
the 135 138 182 185 O
study 139 144 186 191 O

Magnesium 0 9 192 201 B-clinical_variable
< 10 11 202 203 O
1.4 12 15 204 207 B-upper_bound
mg 16 18 208 210 I-upper_bound
/ 18 19 210 211 I-upper_bound
dl 19 21 211 213 I-upper_bound
( 22 23 214 215 O
< 23 24 215 216 O
0.4 25 28 217 220 B-upper_bound
mmol 29 33 221 225 I-upper_bound
/ 33 34 225 226 I-upper_bound
L 34 35 226 227 I-upper_bound
) 35 36 227 228 O
or 37 39 229 231 O
> 40 41 232 233 O
3 42 43 234 235 B-lower_bound
mg 44 46 236 238 I-lower_bound
/ 46 47 238 239 I-lower_bound
dl 47 49 239 241 I-lower_bound
( 50 51 242 243 O
> 51 52 243 244 O
1.23 53 57 245 249 B-lower_bound
mmol 58 62 250 254 I-lower_bound
/ 62 63 254 255 I-lower_bound
L 63 64 255 256 I-lower_bound
) 64 65 256 257 O
despite 66 73 258 265 O
intervention 74 86 266 278 O
to 87 89 279 281 O
normalize 90 99 282 291 O
levels 100 106 292 298 O

Negative 0 8 299 307 B-pregnancy
pregnancy 9 18 308 317 I-pregnancy
test 19 23 318 322 O

Patients 0 8 323 331 O
must 9 13 332 336 O
agree 14 19 337 342 O
to 20 22 343 345 O
pre- 23 27 346 350 O
and 28 31 351 354 O
post 32 36 355 359 O
- 36 37 359 360 O
treatment 37 46 360 369 O
biopsies 47 55 370 378 B-treatment

Patients 0 8 379 387 O
must 9 13 388 392 O
have 14 18 393 397 O
an 19 21 398 400 O
Eastern 22 29 401 408 B-clinical_variable
Cooperative 30 41 409 420 I-clinical_variable
Oncology 42 50 421 429 I-clinical_variable
Group 51 56 430 435 I-clinical_variable
( 57 58 436 437 I-clinical_variable
ECOG 58 62 437 441 I-clinical_variable
) 62 63 441 442 I-clinical_variable
performance 64 75 443 454 I-clinical_variable
status 76 82 455 461 I-clinical_variable
= 83 84 462 463 O
< 84 85 463 464 O
2 86 87 465 466 B-upper_bound

Patients 0 8 467 475 O
must 9 13 476 480 O
have 14 18 481 485 O
untreated 19 28 486 495 O
or 29 31 496 498 O
relapsed 32 40 499 507 O
SCCS 41 45 508 512 O
that 46 50 513 517 O
is 51 53 518 520 O
considered 54 64 521 531 O
to 65 67 532 534 O
be 68 70 535 537 O
aggressive 71 81 538 548 O
and 82 85 549 552 O
locally 86 93 553 560 O
advanced 94 102 561 569 O
by 103 105 570 572 O
the 106 109 573 576 O
following 110 119 577 586 O
criteria 120 128 587 595 O
: 128 129 595 596 O
tumors 130 136 597 603 B-cancer
2 137 138 604 605 B-lower_bound
cm 139 141 606 608 I-lower_bound
or 142 144 609 611 O
more 145 149 612 616 O
, 149 150 616 617 O
tumors 151 157 618 624 O
invading 158 166 625 633 O
deep 167 171 634 638 O
tissues 172 179 639 646 O
such 180 184 647 651 O
as 185 187 652 654 O
muscle 188 194 655 661 O
, 194 195 661 662 O
cartilage 196 205 663 672 O
or 206 208 673 675 O
bone 209 213 676 680 O
; 213 214 680 681 O
tumors 215 221 682 688 O
showing 222 229 689 696 O
perineural 230 240 697 707 O
invasion 241 249 708 716 O
, 249 250 716 717 O
and/or 251 257 718 724 O
tumors 258 264 725 731 O
metastatic 265 275 732 742 O
to 276 278 743 745 O
loco 279 283 746 750 O
- 283 284 750 751 O
regional 284 292 751 759 O
lymph 293 298 760 765 O
nodes 299 304 766 771 O
; 304 305 771 772 O
patients 306 314 773 781 O
may 315 318 782 785 O
have 319 323 786 790 O
had 324 327 791 794 O
prior 328 333 795 800 O
surgical 334 342 801 809 O
interventions 343 356 810 823 O
or 357 359 824 826 O
been 360 364 827 831 O
treated 365 372 832 839 O
with 373 377 840 844 O
investigational 378 393 845 860 O
agents 394 400 861 867 O
with 401 405 868 872 O
residual 406 414 873 881 O
or 415 417 882 884 O
recurrent 418 427 885 894 O
disease 428 435 895 902 O

Potassium 0 9 903 912 B-clinical_variable
< 10 11 913 914 O
3.5 12 15 915 918 B-upper_bound
mmol 16 20 919 923 I-upper_bound
/ 20 21 923 924 I-upper_bound
L 21 22 924 925 I-upper_bound
or 23 25 926 928 O
> 26 27 929 930 O
6 28 29 931 932 B-lower_bound
mmol 30 34 933 937 I-lower_bound
/ 34 35 937 938 I-lower_bound
L 35 36 938 939 I-lower_bound
despite 37 44 940 947 O
intervention 45 57 948 960 O
to 58 60 961 963 O
normalize 61 70 964 973 O
levels 71 77 974 980 O

Prior 0 5 981 986 B-treatment
radiation 6 15 987 996 I-treatment
therapy 16 23 997 1004 I-treatment
is 24 26 1005 1007 O
not 27 30 1008 1011 O
an 31 33 1012 1014 O
exclusion 34 43 1015 1024 O
however 44 51 1025 1032 O
, 51 52 1032 1033 O
patient 53 60 1034 1041 O
must 61 65 1042 1046 O
have 66 70 1047 1051 O
documented 71 81 1052 1062 O
progression 82 93 1063 1074 O
at 94 96 1075 1077 O
the 97 100 1078 1081 O
radiation 101 110 1082 1091 O
site 111 115 1092 1096 O

Second 0 6 1097 1103 O
primary 7 14 1104 1111 B-cancer
malignancy 15 25 1112 1122 I-cancer
only 26 30 1123 1127 O
if 31 33 1128 1130 O
treatment 34 43 1131 1140 B-treatment
would 44 49 1141 1146 O
interfere 50 59 1147 1156 O
with 60 64 1157 1161 O
the 65 68 1162 1165 O
patient 69 76 1166 1173 O
's 76 78 1173 1175 O
participation 79 92 1176 1189 O
in 93 95 1190 1192 O
this 96 100 1193 1197 O
trial 101 106 1198 1203 O
in 107 109 1204 1206 O
the 110 113 1207 1210 O
opinion 114 121 1211 1218 O
of 122 124 1219 1221 O
the 125 128 1222 1225 O
treating 129 137 1226 1234 O
physician 138 147 1235 1244 O

Serious 0 7 1245 1252 O
concomitant 8 19 1253 1264 O
systemic 20 28 1265 1273 B-chronic_disease
disorders 29 38 1274 1283 I-chronic_disease
( 39 40 1284 1285 O
including 40 49 1285 1294 O
active 50 56 1295 1301 B-chronic_disease
infections 57 67 1302 1312 I-chronic_disease
) 67 68 1312 1313 O
that 69 73 1314 1318 O
would 74 79 1319 1324 O
compromise 80 90 1325 1335 O
the 91 94 1336 1339 O
safety 95 101 1340 1346 O
of 102 104 1347 1349 O
the 105 108 1350 1353 O
patient 109 116 1354 1361 O
or 117 119 1362 1364 O
compromise 120 130 1365 1375 O
the 131 134 1376 1379 O
patient 135 142 1380 1387 O
's 142 144 1387 1389 O
ability 145 152 1390 1397 O
to 153 155 1398 1400 O
complete 156 164 1401 1409 O
the 165 168 1410 1413 O
study 169 174 1414 1419 O
, 174 175 1419 1420 O
at 176 178 1421 1423 O
the 179 182 1424 1427 O
discretion 183 193 1428 1438 O
of 194 196 1439 1441 O
the 197 200 1442 1445 O
investigator 201 213 1446 1458 O

Serum 0 5 1459 1464 B-clinical_variable
calcium 6 13 1465 1472 I-clinical_variable
( 14 15 1473 1474 I-clinical_variable
ionized 15 22 1474 1481 I-clinical_variable
or 23 25 1482 1484 I-clinical_variable
adjusted 26 34 1485 1493 I-clinical_variable
for 35 38 1494 1497 I-clinical_variable
albumin 39 46 1498 1505 I-clinical_variable
) 46 47 1505 1506 I-clinical_variable
< 48 49 1507 1508 O
8 50 51 1509 1510 B-upper_bound
mg 52 54 1511 1513 I-upper_bound
/ 54 55 1513 1514 I-upper_bound
dl 55 57 1514 1516 I-upper_bound
( 58 59 1517 1518 I-upper_bound
1.75 59 63 1518 1522 I-upper_bound
mmol 64 68 1523 1527 I-upper_bound
/ 68 69 1527 1528 I-upper_bound
L 69 70 1528 1529 I-upper_bound
) 70 71 1529 1530 I-upper_bound
or 72 74 1531 1533 O
> 75 76 1534 1535 O
12.5 77 81 1536 1540 B-lower_bound
mg 82 84 1541 1543 I-lower_bound
/ 84 85 1543 1544 I-lower_bound
dl 85 87 1544 1546 I-lower_bound
( 88 89 1547 1548 I-lower_bound
> 89 90 1548 1549 I-lower_bound
3.1 91 94 1550 1553 I-lower_bound
mmol 95 99 1554 1558 I-lower_bound
/ 99 100 1558 1559 I-lower_bound
L 100 101 1559 1560 I-lower_bound
) 101 102 1560 1561 I-lower_bound
despite 103 110 1562 1569 O
intervention 111 123 1570 1582 O
to 124 126 1583 1585 O
normalize 127 136 1586 1595 O
levels 137 143 1596 1602 O

Women 0 5 1603 1608 B-gender
who 6 9 1609 1612 O
are 10 13 1613 1616 O
pregnant 14 22 1617 1625 B-pregnancy

age 0 3 1626 1629 B-age
must 4 8 1630 1634 O
agree 9 14 1635 1640 O
to 15 17 1641 1643 O
undergo 18 25 1644 1651 O
a 26 27 1652 1653 O
pregnancy 28 37 1654 1663 B-pregnancy
test 38 42 1664 1668 O
prior 43 48 1669 1674 O
to 49 51 1675 1677 O
therapy 52 59 1678 1685 B-treatment
and 60 63 1686 1689 O
to 64 66 1690 1692 O
use 67 70 1693 1696 B-contraception_consent
adequate 71 79 1697 1705 I-contraception_consent
contraception 80 93 1706 1719 I-contraception_consent
( 94 95 1720 1721 O
hormonal 95 103 1721 1729 B-contraception_consent
or 104 106 1730 1732 I-contraception_consent
barrier 107 114 1733 1740 I-contraception_consent
method 115 121 1741 1747 I-contraception_consent
of 122 124 1748 1750 I-contraception_consent
birth 125 130 1751 1756 I-contraception_consent
control 131 138 1757 1764 I-contraception_consent
; 138 139 1764 1765 O
abstinence 140 150 1766 1776 B-contraception_consent
) 150 151 1776 1777 O
prior 152 157 1778 1783 O
to 158 160 1784 1786 O
study 161 166 1787 1792 O
entry 167 172 1793 1798 O
, 172 173 1798 1799 O
for 174 177 1800 1803 O
the 178 181 1804 1807 O
duration 182 190 1808 1816 O
of 191 193 1817 1819 O
study 194 199 1820 1825 O
participation 200 213 1826 1839 O
and 214 217 1840 1843 O
for 218 221 1844 1847 O
6 222 223 1848 1849 B-upper_bound
months 224 230 1850 1856 I-upper_bound
after 231 236 1857 1862 O
; 236 237 1862 1863 O
should 238 244 1864 1870 O
a 245 246 1871 1872 O
woman 247 252 1873 1878 B-gender
become 253 259 1879 1885 B-pregnancy
pregnant 260 268 1886 1894 I-pregnancy
or 269 271 1895 1897 O
suspect 272 279 1898 1905 O
she 280 283 1906 1909 O
is 284 286 1910 1912 O
pregnant 287 295 1913 1921 O
while 296 301 1922 1927 O
participating 302 315 1928 1941 O
in 316 318 1942 1944 O
this 319 323 1945 1949 O
study 324 329 1950 1955 O
, 329 330 1955 1956 O
she 331 334 1957 1960 O
should 335 341 1961 1967 O
inform 342 348 1968 1974 O
her 349 352 1975 1978 O
treating 353 361 1979 1987 O
physician 362 371 1988 1997 O
immediately 372 383 1998 2009 O

patient 0 7 2010 2017 O
had 8 11 2018 2021 O
a 12 13 2022 2023 O
second 14 20 2024 2030 B-cancer
primary 21 28 2031 2038 I-cancer
malignancy 29 39 2039 2049 I-cancer
but 40 43 2050 2053 O
has 44 47 2054 2057 O
been 48 52 2058 2062 O
treated 53 60 2063 2070 O
and 61 64 2071 2074 O
disease 65 72 2075 2082 O
free 73 77 2083 2087 O
for 78 81 2088 2091 O
at 82 84 2092 2094 O
least 85 90 2095 2100 O
3 91 92 2101 2102 B-lower_bound
years 93 98 2103 2108 I-lower_bound

women 0 5 2109 2114 B-gender
of 6 8 2115 2117 O
childbearing 9 21 2118 2130 O

